Detalhe da pesquisa
1.
Available information about paediatric use of onco-haematological drugs authorized by EMA since 2016.
J Oncol Pharm Pract
; 29(1): 83-87, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34693799
2.
A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductions.
J Oncol Pharm Pract
; 29(8): 1806-1815, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35903919
3.
Randomized clinical trials and real life studies: Comparison of baseline characteristics of patients in oral target therapies for renal cell carcinoma.
J Oncol Pharm Pract
; 28(4): 870-883, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33847190
4.
Adherence, persistence and treatment switching in psoriasis.
Immunotherapy
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38651935
5.
Safety and Effectiveness of Multiple Switching Between Originators and Biosimilars: Literature Review and Status Report on Interchangeability.
Ther Innov Regul Sci
; 57(2): 352-364, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36322326
6.
Medication adherence reporting in pivotal clinical trials: overview of oral oncological drugs.
Eur J Hosp Pharm
; 30(6): 328-332, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35058307
7.
ADA_ETA_BIO2021: real-world evaluation of adherence, persistence, and cost-effectiveness of originator and biosimilar biologic drugs in the treatment of rheumatoid arthritis: a multicenter study in Italy.
Curr Med Res Opin
; 39(12): 1729-1735, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994874